Table 2.
Demographic features of the patients
| Characteristics | HATCH score |
p value | |
|---|---|---|---|
| ≤2 (n = 274) | >2 (n = 78) | ||
| Age, years | 61.7±12.4 | 65.9±11.7 | 0.014a |
| Gender, male, n (%) | 195 (71.1) | 54 (69.2) | 0.799 |
| Hypertension, n (%) | 149 (54.3) | 56 (71.7) | 0.012 |
| Diabetes mellitus, n (%) | 84 (30.6) | 18 (23) | 0.421 |
| Ejection fraction, %, | 48.9±9.5 | 47.6±9.8 | 0.567a |
| Preoperative cerebrovascular accident, n (%) | 33 (12) | 16 (20.5) | 0.173 |
| Preoperative PCI, n (%) | 57 (20.8) | 18 (23) | 0.876 |
| Chronic obstructive pulmonary disease, n (%) | 28 (10.2) | 15 (19.2) | 0.189 |
| Peripheral artery disease, n (%) | 22 (8) | 8 (10.2) | 0.356 |
| β-Blocker therapy, n (%) | 221 (80.6) | 64 (82) | 0.757 |
| ARB/ACE-I therapy, n (%) | 83 (30.2) | 22 (28.2) | 0.815 |
| SYNTAX score I | 18 (12–28) | 18 (14–35) | 0.001b |
| Postoperative atrial fibrillation (+), n (%) | 61 (22.2) | 33 (42.3) | <0.001 |
| Body mass index, kg/m2 | 26.56±5.48 | 27.26±4.28 | 0.454a |
Means ± SD, medians (ranges), and numbers (%) are shown. PCI, percutaneous coronary intervention; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker. Significant values are italicized.
a
Student t test.
b
Mann-Whitney U test, Pearson χ2 test.